4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
China Risun Group Limited (1907) operates in the Chemicals industry and is headquartered in Causeway Bay, Hong Kong with about 7,131 employees. Its market capitalization is roughly CNY 8 billion. In the fiscal year ended 2025-12-31, 1907 reported CNY 39.3B in revenue and CNY 58M in net income.
China Risun Group Limited, together with its subsidiaries, produces and supplies coke, coking chemicals, and refined chemicals in the People's Republic of China. It operates in five segments: Coke and Coking Chemicals Manufacturing, Refined Chemicals Manufacturing, Operation Management, Trading, and Others.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 39.3B | CNY 47.5B | CNY 46.1B | CNY 43.1B |
| Gross Profit | CNY 3.1B | CNY 3.5B | CNY 3.3B | CNY 4.3B |
| Operating Income (EBIT) | CNY 1.0B | CNY 1.2B | CNY 1.4B | CNY 2.4B |
| Net Income | CNY 58M | CNY 20M | CNY 861M | CNY 1.9B |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 104M) | (CNY 87M) | (CNY 257M) | (CNY 824M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 61.9B | CNY 59.8B | CNY 53.8B | CNY 46.1B | — |
| Total Liabilities | CNY 46.8B | CNY 44.0B | CNY 39.4B | CNY 33.5B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1907 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms